Los cambios estructurales de la apolipoproteína A-I causados por el almidón hidroxietil 130/0.4 revelan mecanismos

Lingyan Qu1, Liqun Jia2, Jianzhong Zhang1

  • 1Department of Anesthesiology, Yantaishan Hospital Affiliated to Binzhou Medical University, Yantai, 264003, China.

The protein journal
|August 30, 2025
PubMed
Resumen

El almidón hidroxietil (HES 130/0,4) interactúa con la Apolipoproteína A-I (ApoA-I), alterando su estructura y fluorescencia. Este estudio aclara los mecanismos de unión de HES 130/0.4 con ApoA-I in vitro.

Videos de Conceptos Relacionados

Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
112
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.8K
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
272